Applying intelligently glycemic control and a systematic route through the BBB (blood-brain barrier) to effectively reach neurons. Venture Valuation (VV) interviewed the CEO, Mariko Tosu, PhD
Would you like to be notified about new interviews, reports and other valuable content published by Venture Valuation?